ProBioGen

ProBioGen is a German-based biotech company that specializes in the development and production of customized cell lines for the pharmaceutical industry. They offer a wide range of services in cell line development, ensuring that their clients have access to the most suitable cell lines for their needs. ProBioGen's cell engineering technology includes the use of genetic modification, which enables them to modify cells for specific purposes such as the production of antibodies or vaccines. Additionally, the company applies their expertise in the fields of cell line engineering, process development and analytical methods to offer solutions for large scale cell culture and manufacturing of biopharmaceuticals.

ProBioGen's ADCC (antibody dependent cell mediated cytotoxicity) expert platform is a unique technology enabling the company to offer a variety of optimized ADCC assay formats allowing for in-depth characterization of antibodies or cells. ProBioGen's development and production services include the use of the latest technologies to deliver high-yield, stable, and high-quality cell lines. Their quality management system includes adherence to regulatory demands and standards such as GMP (Good Manufacturing Practice) norms and the International Organization for Standardization (ISO). ProBioGen's customized services cater to clients' specific requirements, ensuring that their clients' cell line needs are met within the stipulated timeline, thereby simplifying their clients' drug development process.